China National Accord Medicines Corporation Ltd. announced earnings results for the year ended December 31, 2016. For the period the company’s total operating profit was RMB 41,248,429,300 as compared to RMB 37,819,278,000 for the same period last year. Net profit attributable to shareholders was RMB 1,186,601,900 as compared to RMB 927,610,200 for the same period last year. Basic earnings per share were RMB 2.80 as compared to RMB 2.19 for the same period last year. Weighted average ROE was 15.08% as compare to 13.43% for the same period last year.